Metagenomi, Inc. (NASDAQ: MGX) reported Q2 EPS of ($0.29), $0.41 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $20 million.

For earnings history and earnings-related data on Metagenomi, Inc. (MGX) click here.